KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0688 $0.257 Friday, 26th Apr 2024 JAGX stock ended at $0.180. This is 5.88% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 17.29% from a day low at $0.166 to a day high of $0.195.
90 days $0.0519 $0.257
52 weeks $0.0519 $1.22

Historical Jaguar Health, Inc. prices

Date Open High Low Close Volume
Feb 14, 2024 $0.0817 $0.0826 $0.0783 $0.0811 10 677 235
Feb 13, 2024 $0.0900 $0.0900 $0.0800 $0.0819 12 713 145
Feb 12, 2024 $0.0888 $0.0957 $0.0860 $0.0894 22 573 979
Feb 09, 2024 $0.0891 $0.0894 $0.0766 $0.0837 14 082 609
Feb 08, 2024 $0.0880 $0.0928 $0.0872 $0.0887 10 143 743
Feb 07, 2024 $0.0895 $0.0939 $0.0883 $0.0897 9 933 546
Feb 06, 2024 $0.0887 $0.0930 $0.0871 $0.0929 10 171 092
Feb 05, 2024 $0.0962 $0.0962 $0.0871 $0.0891 14 118 506
Feb 02, 2024 $0.100 $0.101 $0.0930 $0.0968 11 838 039
Feb 01, 2024 $0.100 $0.102 $0.0956 $0.0997 14 437 330
Jan 31, 2024 $0.110 $0.113 $0.101 $0.104 18 640 575
Jan 30, 2024 $0.107 $0.116 $0.101 $0.110 20 217 876
Jan 29, 2024 $0.109 $0.109 $0.100 $0.105 20 403 380
Jan 26, 2024 $0.141 $0.148 $0.111 $0.113 102 027 203
Jan 25, 2024 $0.103 $0.119 $0.0982 $0.115 23 783 815
Jan 24, 2024 $0.0972 $0.105 $0.0963 $0.103 10 881 120
Jan 23, 2024 $0.104 $0.105 $0.0972 $0.0993 9 667 921
Jan 22, 2024 $0.102 $0.104 $0.0954 $0.103 7 858 458
Jan 19, 2024 $0.100 $0.105 $0.0955 $0.101 6 317 180
Jan 18, 2024 $0.103 $0.107 $0.0915 $0.105 8 880 711
Jan 17, 2024 $0.0930 $0.101 $0.0860 $0.0999 10 858 765
Jan 16, 2024 $0.0979 $0.100 $0.0856 $0.0953 15 350 762
Jan 12, 2024 $0.117 $0.126 $0.102 $0.103 52 286 171
Jan 11, 2024 $0.116 $0.116 $0.106 $0.108 5 425 998
Jan 10, 2024 $0.119 $0.120 $0.113 $0.115 4 527 165
Click to get the best stock tips daily for free!

About Jaguar Health, Inc.

Jaguar Health. Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer fo... JAGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT